Bioceres Crop Solutions BIOX Estimates

NASDAQ BIOX
$0.43 +0.00 (+1.04%)
At close: Sep 9, 2026 · 4:00 PM EDT
Analyst Estimates

Bioceres Crop Solutions Corp. Revenue Estimates

Periods 25
Next Period Q2 26
Consensus 98.42 M

Analysts expect Bioceres Crop Solutions Corp. to report revenue of 98.42 M for Q2 26, against a range of 91.51 M to 105.33 M. The most recent reported quarter, Q3 26, came in at 39.40 M, a 25.7% miss against the 53.01 M consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 124.00 M93.30 M106.70 M60.60 M74.70 M77.50 M-39.40 M-------
High Estimate 134.93 M112.56 M127.74 M63.79 M123.48 M96.52 M105.33 M57.62 M87.97 M113.97 M124.35 M60.06 M108.74 M132.71 M192.18 M
Low Estimate 117.36 M97.60 M107.00 M57.11 M109.79 M80.16 M91.51 M48.40 M78.79 M93.96 M111.38 M54.84 M96.49 M109.76 M160.88 M
Consensus Estimate 126.15 M105.08 M117.37 M60.45 M116.63 M88.34 M98.42 M53.01 M83.38 M103.96 M117.86 M57.45 M102.62 M121.23 M176.53 M
Analyst Estimates

Bioceres Crop Solutions Corp. Earnings Per Share (EPS) Estimates

Periods 25
Next Period Q2 26
Consensus 0.07

Analysts expect Bioceres Crop Solutions Corp. to report earnings per share of 0.07 for Q2 26, against a range of 0.06 to 0.08. The most recent reported quarter, Q3 26, came in at -0.16, a 220.0% miss against the -0.05 consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.03-0.080.01-0.02-0.70-0.12--0.16-------
High Estimate 0.23-0.020.11-0.130.08-0.060.08-0.05-0.050.070.18-0.06-0.130.210.34
Low Estimate 0.21-0.020.09-0.130.06-0.060.06-0.05-0.070.050.16-0.06-0.130.190.30
Consensus Estimate 0.22-0.020.10-0.130.07-0.060.07-0.05-0.060.060.17-0.06-0.130.200.32